Advertisement
Table 1 Baseline characteristics of all enrolled patients
| Characteristic | Laparoscopic group | Open surgery group (control) | P value |
|---|---|---|---|
| Sex (cases) | 0.904 | ||
| Men | 26 | 27 | |
| Women | 5 | 6 | |
| Age (years) | 0.413 | ||
| Median | 54 | 59.5 | |
| Range | 37–66 | 34–65 | |
| BMI | 0.912 | ||
| Median | 24.4 | 25.0 | |
| Range | 19.1–31.0 | 21.8–29.9 | |
| Initial surgical lesion site (cases) | 0.665 | ||
| Right lobe | 22 | 25 | |
| Left lobe | 9 | 8 | |
| Primary tumor size (cm) | 4.1 ± 1.5 | 4.9 ± 2.6 | 0.382 |
| Time to recurrence (months) | 28.4 ± 27.7 | 27.5 ± 16.3 | 0.282 |
| Size of recurrent tumor (cm) | 2.5 ± 1.0 | 3.8 ± 1.1 | 0.45 |
| Recurrent site (cases) | 0.632 | ||
| Right lobe | 16 | 19 | |
| Left lobe | 15 | 14 | |
| Operation method (cases) | 0.955 | ||
| Left lateral lobectomy | 12 | 13 | |
| Local resection | 19 | 20 | |
| Total bilirubin (μmol/L) | 31.2 ± 7.4 | 33.7 ± 10.4 | 0.742 |
| Albumin (g/L) | 35.2 ± 3.3 | 36.4 ± 4.3 | 0.532 |
| ALT (U/L) | 49.6 ± 6.4 | 76.3 ± 7.5 | 0.671 |
| AST (U/L) | 52.4 ± 7.4 | 69.4 ± 8.4 | 0.832 |
| Prothrombin time (s) | 11.5 ± 0.7 | 12.4 ± 1.0 | 0.651 |
| AFP (cases) | 0.264 | ||
| >400 ng/mL | 27 | 24 | |
| <400 ng/mL | 4 | 9 | |
| HBV-DNA (log10 IU/mL) | 3.50 ± 0.8 | 3.0 ± 0.2 | 0.192 |
